ClinConnect ClinConnect Logo
Search / Trial NCT06324955

Language During Inhalational Induction

Launched by BOSTON CHILDREN'S HOSPITAL · Mar 15, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Anesthesia Induction

ClinConnect Summary

This clinical trial is studying how the way doctors talk to children during the start of anesthesia can affect their feelings and behavior. Specifically, it compares the use of standard language that doctors usually use with more positive, encouraging language. The goal is to see if using positive language can help reduce anxiety and negative behaviors, like confusion or distress, in children aged 5 to 10 who need anesthesia for non-emergency procedures.

To participate in this study, children must be generally healthy (classified as ASA 1 or 2) and not have any previous experiences with inhalational induction, which is a common method of starting anesthesia using gas. Children with certain conditions, like hearing difficulties or behavioral issues, are not eligible. If chosen to participate, children will be randomly assigned to either the standard language group or the positive language group, and their reactions will be observed during the process. This research could help improve the experience of children undergoing anesthesia in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ASA 1 and 2 (Healthy Patients)
  • Non-emergent cases
  • 5-10 year olds
  • Patients receiving inhalational induction
  • Exclusion Criteria:
  • Non-English speaking
  • History of prior inhalational inductions
  • Hearing difficulty
  • Behavioral difficulty (Autism, Oppositional Defiant Disorder)
  • Patients receiving premedication other than midazolam

About Boston Children's Hospital

Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.

Locations

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

John Fiadjoe, MD

Principal Investigator

Boston Children's Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported